Evidence map›Paper›PMID 30789452›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2019

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study.

Barbara Rossetti, Roberta Gagliardini, Gaetana Sterrantino, Vincenzo Colangeli, Alessandra Latini, Manuela Colafigli, Francesca Vignale, Stefano Rusconi, Antonio Di Biagio, Giancarlo Orofino and 13 more

Abstract readLetterRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Barbara RossettiInfectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Roberta GagliardiniDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Gaetana SterrantinoClinic of Infectious Diseases, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.
Vincenzo ColangeliClinic of Infectious Diseases, Azienda Ospedaliera Universitaria S.Orsola Malpighi, Bologna, Italy.
Alessandra LatiniInfectious Dermatology and Allergology IRCCS IFO, Roma, Italy.
Manuela ColafigliInfectious Dermatology and Allergology IRCCS IFO, Roma, Italy.
Francesca VignaleClinic of Infectious Diseases, G. D'Annunzio University, Chieti, Italy.
Stefano RusconiInfectious and Tropical Diseases Unit, DIBIC L. Sacco Hospital, University of Milano, Italy.
Antonio Di BiagioInfectious Diseases Unit, IRCCS S. Martino-IST, Genova, Italy.
Giancarlo OrofinoInfectious Diseases Unit A, Amedeo di Savoia Hospital, Torino, Italy.
Ivano MezzaromaDepartment of Translational and Precision Medicine, Sapienza University of Rome, Roma, Italy.
Vincenzo VulloDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Roma, Italy.
Daniela FrancisciClinic of Infectious Diseases, University of Perugia, Perugia, Italy.
Claudio MastroianniInfectious Disease Unit, SM Goretti Hospital, Department of Public Health and Infectious Diseases, Sapienza University, Latina, Italy.
Michele TrezziInfectious Diseases Unit, Pistoia Hospital, Italy.
Benedetta CanovariInfectious Diseases Unit, Pesaro Hospital, Italy.
Silvia LamonicaClinic of Infectious Diseases, Catholic University of Sacred Heart, Roma, Italy.
Arturo CicculloClinic of Infectious Diseases, Catholic University of Sacred Heart, Roma, Italy.
Alberto BorghettiClinic of Infectious Diseases, Catholic University of Sacred Heart, Roma, Italy.
Antonella DʼArminio MonforteInfectious and Tropical Diseases Institute, Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy.
Simona Di GiambenedettoClinic of Infectious Diseases, Catholic University of Sacred Heart, Roma, Italy.
Andrea De LucaInfectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
for GUSTA trial study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiretroviral Therapy, Highly ActiveAnti-HIV AgentsDarunavirDisease ProgressionDrug SubstitutionFemaleHIV-1HIV InfectionsHumansLiver CirrhosisMaleMaravirocMiddle AgedRitonavirAnti-HIV AgentsDarunavirMaravirocRitonavir

Identifiers

PMID30789452
PMCPMC6467556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.